Skip to main content
T&R Biofab Co., Ltd logo

T&R Biofab Co., Ltd — Investor Relations & Filings

Ticker · 246710 ISIN · KR7246710008 KO Manufacturing
Open in API
Filings indexed 415 across all filing types
Latest filing 2026-03-03 Proxy Solicitation & In…
Country KR South Korea
Listing KO 246710

About T&R Biofab Co., Ltd

http://www.tnrbiofab.com/en/

T&R Biofab Co., Ltd. is a biomedical engineering company specializing in the development and commercialization of regenerative medical technologies. The company utilizes its proprietary 3D bioprinting technology to manufacture a range of products. Its primary offerings include 3D-printed, bioresorbable medical scaffolds designed to aid in the regeneration and reconstruction of tissues and organs. Other key business areas encompass bio-surgical solutions, the development of organoids and mini-tissues for research and therapeutic applications, and the use of human induced pluripotent stem cells (hiPSC).

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Solicitation of Proxy Statement), which is a standard regulatory filing in South Korea used to provide shareholders with information regarding upcoming general meetings and to solicit their votes. It includes details about the meeting, the agenda, and proxy solicitation procedures. While it contains financial statements, these are provided as supporting information for the shareholders' decision-making process at the meeting, not as a standalone annual report or earnings release.
2026-03-03 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of Convocation of the Annual General Meeting' (주주총회소집공고) for the 13th Annual General Meeting of Shareholders of T&R Biofab. It includes the meeting agenda, voting procedures, and detailed management information (such as board activities, remuneration, and business overview) required for shareholders to make informed decisions. This document is a standard proxy statement/notice package for an upcoming AGM.
2026-03-03 Korean
[기재정정]주식매수선택권부여에관한신고
Regulatory Filings Classification · 95% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically marked as a '정정 신고' (Amendment Report). It details changes to previously granted stock options, including the number of shares and the list of recipients. In the context of financial filings, reports regarding stock option grants, amendments, or cancellations are classified under 'Regulatory Filings' (RNS) as they represent specific corporate disclosures to regulatory bodies that do not fall into more specific categories like 'Director's Dealing' (which usually refers to personal trades) or 'Share Issue' (which refers to capital changes).
2026-02-26 Korean
[기재정정]주식매수선택권부여에관한신고
Regulatory Filings Classification · 95% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고 정정신고' (Amendment to the Report on Stock Option Grant). It details changes to previously reported stock option grants, including the number of recipients and the number of shares, due to cancellations. This type of filing is a standard regulatory disclosure regarding capital structure and equity compensation, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for new capital).
2026-02-26 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 95% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically identified as a '정정신고' (Amendment Report). It details changes to previously granted stock options, including the number of recipients and the number of shares, and provides updated exercise prices and conditions. This type of filing is a standard regulatory disclosure regarding equity compensation and capital structure, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for new capital issuance).
2026-02-26 Korean
[기재정정]주식매수선택권부여에관한신고
Regulatory Filings Classification · 95% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is specifically a '정정신고' (Amendment Report). It details changes to previously reported stock option grants, including the number of recipients and the number of shares, due to cancellations. This type of disclosure regarding stock option plans and their amendments falls under general regulatory filings for corporate governance and capital structure, which is best categorized as RNS (Regulatory Filings) as it does not fit into specific categories like DIRS (which is for individual director trades) or SHA (which is for new share issues).
2026-02-26 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.